## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -3.0% below STRENGTH zone (3.0-6.0%); PEG 1.04 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1865.35)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. MercadoLibre (MELI) Stock: Falls 5% Amid Rising Credit Risk and Bond Issuance**
- Source: CoinCentral | 20251211T091029 | Neutral | Relevance: 99%
- MercadoLibre (MELI) stock fell 5% due to concerns over rising credit risk within its Mercado Pago portfolio, a $750 million bond issuance, and operational expenses related to a new robotics partnership. Despite short-term volatility and a "Strong Sell" technical rating, analysts remain bullish on MELI's long-term growth prospects in Latin American e-commerce and fintech, with price targets suggesting significant upside. Investors are watching key support levels and macroeconomic factors while considering the balance between aggressive expansion and profitability.

**2. MercadoLibre completes $750 million offering of 4.900% notes due 2033**
- Source: Investing.com | 20251209T221008 | Bullish | Relevance: 97%
-  MercadoLibre, Inc. successfully closed an underwritten public offering of $750 million in 4.900% notes due 2033. The notes were issued under the company's existing shelf registration statement and are guaranteed by several MercadoLibre subsidiaries. This information is based on a press release included in MercadoLibreâ€™s Form 8-K filing with the SEC.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |
| 2025-11-14 | BTIG | $2750 | $2750 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |
| 2025-11-14 | BTIG | reit | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 11.1% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.04 suggests fair value with growth premium. Forward P/E 33.0x attractive for 51% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $102.4B |
| Beta | 1.43 |
| 52W Range | $1646.00 - $2645.22 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.04 |
| Forward P/E | 33.0 |
| Current P/E | 49.9 |
| YoY Growth | 51.2% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -1.4% to -3.0% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.0pp (needs >3.0% for momentum thesis). Underperforming sector by 3.9pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram positive (1.78), confirming momentum. RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.98% (CS: 11) | Weak |
| RSI_14 | 43.8 | Neutral |
| MACD Histogram | 1.78 | Bullish |
| vs SMA20 | 0.986x | Below |
| vs SMA50 | 0.949x | Below |
| vs SMA200 | 0.889x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $2019.81
- **Stop Loss:** $1865.35 (7.6% risk)
- **Target:** $2174.27 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 8
- **Position Value:** $16,158.48
- **Portfolio %:** 16.16%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*